腹泻型肠易激综合征已诊断与未诊断个体的症状、医疗资源利用及治疗比较
一项在线调查纳入1,924名有胃肠道症状史者,1,094人(56.9%)符合肠易激综合征罗马III标准,其中830人(43.1%)虽符合标准却无医学诊断。已诊断者中16%报告严重胃肠道症状(评分≥6),高于未诊断者的8%(P<0.05);已诊断者更常报告胃肠道症状对生活质量有不良影响。约40%参与者从初级保健医生处接受肠易激综合征相关治疗;已诊断者中26%、未诊断者中43%未接受胃肠道症状治疗。
要点
- 符合肠易激综合征罗马III标准者中43.1%(830/1,924)无医学诊断。
- 已诊断者严重胃肠道症状(评分≥6)比例为16%,高于未诊断者的8%(P<0.05)。
- 已诊断者中26%、未诊断者中43%未接受胃肠道症状治疗。
核心结论
- 许多有肠易激综合征相关症状的个体未获得医学诊断。
- 肠易激综合征相关症状影响生活质量,但超过三分之一的个体未接受肠易激综合征治疗。
研究设计与样本
- 在线调查,比较有医学诊断与无医学诊断肠易激综合征(罗马III标准)个体的胃肠道症状、就医、健康状况、症状管理和治疗满意度。
- 共1,924名有胃肠道症状史者符合条件并完成调查。
主要发现
- 1,094人(56.9%)符合肠易激综合征标准;830人(43.1%)符合诊断标准但无医学诊断。
- 多数参与者的诊断来自胃肠病学家(45%)或初级保健医生(42%)。
- 已诊断者中16%报告严重胃肠道症状(评分≥6),未诊断者中为8%(P<0.05)。
- 已诊断者更常报告胃肠道症状对生活质量有不良影响。
- 约40%参与者从初级保健医生处接受肠易激综合征相关治疗;已诊断者中26%、未诊断者中43%未接受胃肠道症状治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by symptoms including abdominal pain and altered bowel function. Up to 75% of individuals with IBS may be undiagnosed. The aim of this study was to characterize symptoms, healthcare utilization, and treatments in populations with both diagnosed and undiagnosed IBS. METHODS: An online survey was conducted to compare gastrointestinal (GI) symptoms, healthcare visits, well-being, symptom management, and treatment satisfaction in individuals with and without medically diagnosed IBS (Rome III criteria). Symptom severity, disruptiveness, and treatment satisfaction were rated using a 7-point scale. Adjustments to daily life were determined by predefined survey responses. RESULTS: A total of 1,924 individuals with a history of GI symptoms were eligible and completed the survey. Of these, 1,094 individuals (56.9%) met the criteria for IBS; 830 individuals (43.1%) had no medical diagnosis of IBS despite meeting diagnostic criteria. Most participants received a diagnosis from either gastroenterologists (45%) or primary care physicians (42%). A greater percentage of diagnosed patients had severe GI symptoms (score ≥6) vs. undiagnosed individuals (16% vs. 8%, respectively; P<0.05); diagnosed patients were more likely to report that GI symptoms adversely affected their quality of life. Approximately 40% of participants received IBS-related treatment from primary care physicians; 26% and 43% of diagnosed and undiagnosed individuals, respectively, were not receiving treatment for GI symptoms. CONCLUSIONS: Many individuals with IBS-related symptoms have not been medically diagnosed with IBS. IBS-related symptoms impact quality of life, yet more than one-third of individuals are not receiving treatment for IBS.
引用
- Sayuk GS, Wolf R, Chang L, et al. Comparison of Symptoms, Healthcare Utilization, and Treatment in Diagnosed and Undiagnosed Individuals With Diarrhea-Predominant Irritable Bowel Syndrome. Am J Gastroenterol. 2017. PMID: 28094313. doi:10.1038/ajg.2016.574
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。